Adrenomedullin

DB19102InvestigationalProtein Based Therapies

Adrenomedullin is under investigation in clinical trial NCT06072118 (Adrenomedullin for CADASIL).

Mechanism: Pharmacologically active on Calcitonin gene-related peptide type 1 receptor
Curator reviewed
Code names: ADM

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Adrenomedullin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.